NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

DHR

Danaher Corp

Apr 25 • 04:00PM ET

197.14

Dollar change +0.64
Percentage change 0.33	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: GE HON MMM ROK KEYS ABT TMO MTD BSX

| Held by: VTI VOO SPY IVV VTV XLV VIG VHT IWD MOAT

Scroll to Statements

Index	S&P 500	P/E	38.22	EPS (ttm)	5.16	Insider Own	9.35%	Shs Outstand	715.60M	Perf Week	5.52%
Market Cap	141.09B	Forward P/E	23.01	EPS next Y	8.57	Insider Trans	-0.06%	Shs Float	648.74M	Perf Month	-6.31%
Income	3.77B	PEG	4.64	EPS next Q	1.65	Inst Own	81.34%	Short Float	0.93%	Perf Quarter	-19.80%
Sales	23.82B	P/S	5.92	EPS this Y	2.88%	Inst Trans	0.05%	Short Ratio	1.22	Perf Half Y	-24.55%
Book/sh	71.06	P/B	2.77	EPS next Y	11.31%	ROA	4.63%	Short Interest	6.03M	Perf Year	-22.11%
Cash/sh	2.78	P/C	70.79	EPS next 5Y	8.23%	ROE	7.22%	52W Range	171.00 - 281.70	Perf YTD	-14.12%
Dividend Est.	1.22 (0.62%)	P/FCF	28.78	EPS past 5Y	9.03%	ROI	5.63%	52W High	-30.02%	Beta	0.81
Dividend TTM	1.13 (0.57%)	Quick Ratio	1.05	Sales past 5Y	7.33%	Gross Margin	59.80%	52W Low	15.29%	ATR (14)	8.18
Dividend Ex-Date	Mar 28, 2025	Current Ratio	1.43	EPS Y/Y TTM	-12.75%	Oper. Margin	21.67%	RSI (14)	51.02	Volatility	2.98% 4.64%
Employees	63000	Debt/Eq	0.35	Sales Y/Y TTM	-9.19%	Profit Margin	15.81%	Recom	1.37	Target Price	244.78
Option/Short	Yes / Yes	LT Debt/Eq	0.31	EPS Q/Q	-8.94%	Payout	20.42%	Rel Volume	0.53	Prev Close	196.50
Sales Surprise	3.04%	EPS Surprise	15.52%	Sales Q/Q	-0.95%	Earnings	Apr 22 BMO	Avg Volume	4.96M	Price	197.14
SMA20	2.68%	SMA50	-2.45%	SMA200	-17.43%	Trades		Volume	2,608,658	Change	0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Upgrade	Barclays	Equal Weight → Overweight	$205
Mar-21-25	Upgrade	Goldman	Neutral → Buy	$260
Mar-14-25	Upgrade	Stifel	Hold → Buy	$260
Feb-03-25	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-23-24	Initiated	Scotiabank	Sector Perform
Dec-19-24	Initiated	Guggenheim	Buy	$275
Dec-13-24	Upgrade	BofA Securities	Neutral → Buy	$290
Oct-31-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$285
Oct-01-24	Initiated	Stephens	Overweight	$315
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$280
Jun-03-24	Resumed	Jefferies	Buy	$295
Apr-17-24	Upgrade	HSBC Securities	Hold → Buy	$280
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight	$240
Dec-18-23	Initiated	HSBC Securities	Hold
Dec-13-23	Resumed	Wolfe Research	Peer Perform
Dec-07-23	Downgrade	Goldman	Buy → Neutral	$215 → $205
Jul-19-23	Initiated	Raymond James	Outperform	$270
May-01-23	Initiated	SVB Securities	Outperform	$300
Apr-26-23	Downgrade	BofA Securities	Buy → Neutral	$310 → $250
Apr-18-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $285

Show Previous Ratings

Apr-24-25 04:54AM	Danaher predicts $350M tariff hit, moves to mitigate impact on profits (MedTech Dive)
Apr-23-25 05:30PM	Danaher price target lowered to $240 from $260 at Goldman Sachs (TipRanks)
12:10PM	Danaher Corporation (DHR): Among Top Stocks in Bill Gates' Portfolio with Huge Upside Potential (Insider Monkey)
11:40AM	BLCO or DHR: Which Is the Better Value Stock Right Now? (Zacks)
03:01AM	Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth Amidst Mixed ... (GuruFocus.com)
10:30PM	Loading…
Apr-22-25 10:30PM	Q1 2025 Danaher Corp Earnings Call (Thomson Reuters StreetEvents)
09:35PM	DHR Q1 Earnings: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations (StockStory)
09:35PM	DHR Q1 Earnings Call: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations (StockStory)
04:05PM	S&P Behemoth Danaher Surges On Plans To Navigate Pharma-Tied Tariffs (Investor's Business Daily)
02:22PM	Danaher (DHR) Stock Trades Up, Here Is Why (StockStory)
12:14PM	Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y (Zacks)
11:09AM	Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript (Seeking Alpha)
10:00AM	Analyst Report: Danaher Corporation (Morningstar Research)
09:30AM	Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:28AM	How S&P 500 Stock Danaher Plans To Offset Tariffs After Its 'Solid' First-Quarter Report (Investor's Business Daily)
09:28AM	Loading…
09:28AM	Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan (Investor's Business Daily)
07:10AM	Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
06:17AM	Danaher (NYSE:DHR) Surprises With Q1 Sales, Next Quarter's Sales Guidance is Optimistic (StockStory)
06:07AM	Danaher: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Danaher Reports First Quarter 2025 Results (PR Newswire)
Apr-21-25 10:16AM	Danaher Gears Up to Post Q1 Earnings: Is a Beat in Store? (Zacks)
08:04AM	Danaher (DHR) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Apr-19-25 01:25AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 20 (Seeking Alpha)
Apr-16-25 09:15AM	Exploring Analyst Estimates for Danaher (DHR) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Apr-15-25 01:49PM	Parnassus Core Select ETF Q1 2025 Commentary (Seeking Alpha)
10:00AM	Danaher (DHR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-13-25 05:41PM	Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires? (Insider Monkey)
Apr-11-25 08:28AM	Jim Cramer Calls Out Danaher (DHR) CEO: "Time to Step Up or Step Aside" (Insider Monkey)
03:20AM	Akre Focus Fund Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 01:30PM	Analyst Report: Danaher Corporation (Morningstar Research) -5.80%
11:44AM	Loading…
11:44AM	Here's How Danaher Corporation (DHR) Benefits from Switching Costs (Insider Monkey)
Apr-08-25 02:22PM	Danaher Corporation (DHR): Among Stocks with Buy Ratings that Hedge Funds Love (Insider Monkey)
Apr-07-25 07:28PM	Analyst Report: Danaher Corporation (Morningstar Research)
12:50PM	Tariffs And Tactics: Agilent's Path Through Trade Disruption (Seeking Alpha)
Apr-04-25 09:06PM	Lightning Round: Robinhood has more downside from here, says Jim Cramer (CNBC TV) -8.15%
11:57AM	Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds (Zacks)
09:25AM	Andvari Associates Q1 2025 Letter (Seeking Alpha)
Apr-03-25 07:51AM	Is Danaher Corporation (DHR) a Well-Positioned Company Heading into 2025? (Insider Monkey)
Apr-02-25 07:30AM	3 Wide-Moat Dividend Stars For A Championship Portfolio (Seeking Alpha)
12:10AM	Lord Abbett Dividend Growth Fund Q4 2024 Commentary (Seeking Alpha)
Apr-01-25 04:59PM	Top Analyst Reports for Amazon, Oracle & Merck (Zacks)
04:55PM	Danaher Corporation (DHR): One of the Best Healthcare Stocks to Buy According to Billionaires (Insider Monkey)
Mar-31-25 10:24PM	Danaher: Operational Excellence Meets Cyclical Pause - A Hold Amid Recovery Prospects (Seeking Alpha)
04:35AM	John Hancock U.S. Global Leaders Growth Fund Q4 2024 Commentary (Seeking Alpha)
02:27AM	Danaher Corporation: A Mixed Bag Of Strength And Stagnation (Seeking Alpha)
Mar-30-25 11:19PM	Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations (Seeking Alpha)
09:05AM	Putnam Large Cap Growth Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 04:26PM	Is Danaher Corporation (DHR) the Top Stock to Buy According to Akre Capital Management? (Insider Monkey)
Mar-28-25 10:05AM	Parker-Hannifin Benefits From Business Strength Amid Risks (Zacks)
Mar-27-25 10:40AM	ClearBridge Sustainability Leaders Fund Q4 2024 Commentary (SeekingAlpha)
06:45AM	Trump auto tariffs: Wall Street reacts as stocks slide (Yahoo Finance)
Mar-24-25 05:06PM	8 Upcoming Dividend Increases, Including A King (SeekingAlpha)
02:15PM	Why Danaher Corporation (DHR) is Among the Best Diagnostics Stocks to Invest in Right Now (InsiderMonkey)
Mar-22-25 06:59PM	Danaher Corporation (DHR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil (Insider Monkey)
08:00AM	Danaher: Near 5-Year Low Is A Great Entry Point (SeekingAlpha)
12:31AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 23 (SeekingAlpha)
Mar-21-25 05:40AM	Lazard US Sustainable Equity Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-20-25 04:15PM	Danaher Schedules First Quarter 2025 Earnings Conference Call (PR Newswire)
02:05PM	Lazard US Equity Focus Portfolio Q4 2024 Commentary (SeekingAlpha)
01:26PM	Private equity exec and superfan Bill Chisholm buys the Boston Celtics for $6.1B (SeekingAlpha)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-15-25 09:40AM	Chipotle upgraded, Charter initiated: Wall Streets top analyst calls (TipRanks)
Mar-14-25 04:20PM	Danaher Stock Has Fallen Far Enough. Buy It Now, Says Analyst. (Barrons.com)
Mar-13-25 08:01AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
Mar-12-25 08:29AM	Heres Why Danaher Corporation Corp (DHR) Fell in Q4 (Insider Monkey)
Mar-11-25 05:02AM	Danaher (DHR): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-10-25 08:30AM	Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System (PR Newswire)
Mar-07-25 11:43AM	Why Danaher Corporation (DHR) Is Plunging So Far in 2025? (Insider Monkey)
Mar-04-25 04:02AM	Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks (StockStory)
Feb-28-25 11:30AM	Danaher (DHR) Down 7.8% Since Last Earnings Report: Can It Rebound? (Zacks)
Feb-27-25 09:11AM	Jim Cramer to Danaher (DHR) Management: We Are Getting Restless (Insider Monkey)
Feb-25-25 04:15PM	Danaher to Present at TD Cowen Health Care Conference (PR Newswire)
01:49PM	Danaher Corporation (DHR): Among Bourgeon Capitals Top Stock Picks (Insider Monkey)
Feb-24-25 08:06AM	Heres What Will Drive Danaher Corporations (DHR) Above-Average Growth (Insider Monkey)
Feb-23-25 08:50AM	Is Danaher Corporation (DHR) the Best Scientific Instruments Stock to Buy Right Now? (Insider Monkey)
Feb-20-25 04:45PM	Danaher Announces Appointment of Charles Lamanna to Danaher Board (PR Newswire)
04:15PM	Danaher Increases Quarterly Dividend (PR Newswire)
Feb-12-25 11:34AM	Is Danaher Corporation (DHR) The Best Manufacturing Stock To Buy Now? (Insider Monkey)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
09:21AM	Why Danaher Corporation (DHR) is the Best Medical Device Stock to Buy (Insider Monkey)
Feb-09-25 04:26PM	Jim Cramer Slams Danaher (DHR): Bad Quarter, Smug Management (Insider Monkey)
Feb-08-25 03:17PM	Danaher Corporation (DHR): 'Sharp as a Tack People Who've Lost Their Way,' Says Jim Cramer (Insider Monkey)
Feb-07-25 09:50AM	Johnson Controls price target raised to $93 from $86 at RBC Capital (TipRanks)
Feb-05-25 11:22AM	Johnson Controls Stock Leads S&P Gainers on New CEO, Solid Q1 Results (Investopedia)
Feb-03-25 12:47PM	Is Danaher Corporation (DHR) the Best Cancer Stock to Buy According to Hedge Funds? (Insider Monkey)
11:33AM	Raymond James downgrades Danaher on murky growth outlook (Investing.com)
Feb-01-25 03:44AM	Why Danaher Corporation (DHR) Is Among the Best Long Term Low Risk Stocks to Buy Now (Insider Monkey)
Jan-31-25 04:47PM	Jim Cramer Says He's 'Extremely Disappointed' In Danaher Corporation (DHR) (Insider Monkey)
01:11PM	Danahers (NYSE:DHR) Q4 Sales Beat Estimates (StockStory)
07:31AM	Danaher price target lowered to $260 from $265 at Stifel (TipRanks)
02:15AM	Danaher Corp (DHR) Q4 2024 Earnings Call Highlights: Strategic Growth Amid Market Challenges (GuruFocus.com)
Jan-30-25 06:59AM	Why Danaher Corp. (DHR) Crashed on Wednesday? (Insider Monkey)
12:14AM	Q4 2024 Danaher Corp Earnings Call (Thomson Reuters StreetEvents)
Jan-29-25 03:37PM	Analyst Report: Danaher Corporation (Morningstar Research) -9.73%
12:18PM	Danaher Stock Tanks 8.6% After Rare Earnings Miss--Is the Growth Story Cracking? (GuruFocus.com)
11:00AM	Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
10:20AM	Danaher Stock Falls the Most Since 2023. Why Earnings Were Such a Disappointment. (Barrons.com)
08:56AM	Danaher Had an Unusual Quarter. The Stock Is Down. (Barrons.com)
07:10AM	Danaher (DHR) Lags Q4 Earnings Estimates (Zacks)
06:56AM	Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag (Benzinga)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Glenstone Foundation	See Remarks	Apr 24 '25	Proposed Sale	196.50	598,281	117,562,216		Apr 24 05:28 PM
King William	Former Officer	Mar 11 '25	Proposed Sale	207.14	64,697	13,401,340		Mar 11 04:03 PM
King William	Officer	Feb 21 '25	Proposed Sale	209.97	114,351	24,010,531		Feb 21 04:18 PM
Sabeti Pardis C	former Board of Directors	Feb 18 '25	Proposed Sale	204.28	4,337	885,953		Feb 18 01:04 PM
SPOON ALAN G	Director	Feb 07 '25	Option Exercise	59.34	3,928	233,088	121,068	Feb 10 05:00 PM
SPOON ALAN G	Director	Feb 07 '25	Sale	206.46	550	113,553	120,518	Feb 10 05:00 PM
SPOON ALAN G	Director	Feb 07 '25	Proposed Sale	206.46	550	113,553		Feb 07 03:34 PM
Ellis Brian W	Senior Vice President - GC	Jan 30 '25	Option Exercise	58.59	5,700	333,963	25,930	Jan 31 05:00 PM
Ellis Brian W	Senior Vice President - GC	Jan 30 '25	Sale	224.13	5,700	1,277,541	20,230	Jan 31 05:00 PM
Ellis Brian W	Officer	Jan 30 '25	Proposed Sale	224.13	5,700	1,277,542		Jan 30 12:56 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Option Exercise	58.59	26,318	1,541,972	41,543	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Sale	236.59	26,318	6,226,497	15,225	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 25 '24	Sale	238.00	8,370	1,992,060	15,225	Nov 27 05:01 PM
Raskas Daniel	Officer	Nov 26 '24	Proposed Sale	236.59	26,318	6,226,496		Nov 26 04:40 PM
Raskas Daniel	Officer	Nov 25 '24	Proposed Sale	238.00	8,370	1,992,060		Nov 25 12:04 PM
Glenstone Foundation	See Remarks	Nov 05 '24	Proposed Sale	247.76	100,000	24,776,000		Nov 05 04:01 PM
Weidemanis Joakim	Former Director	Oct 23 '24	Proposed Sale	254.95	17,659	4,502,216		Oct 23 01:10 PM
Couchara Georgeann	SVP, Human Resources	Aug 26 '24	Sale	268.37	952	255,483	4,212	Aug 27 05:04 PM
Couchara Georgeann	Officer	Aug 26 '24	Proposed Sale	268.37	952	255,483		Aug 26 04:40 PM
Glenstone Foundation	See Remarks	Aug 13 '24	Proposed Sale	267.20	47,937	12,808,766		Aug 13 04:05 PM
Blair Rainer	President & CEO	Jul 31 '24	Sale	280.00	9,007	2,521,960	97,983	Aug 02 05:00 PM
FILLER LINDA	Director	Aug 01 '24	Option Exercise	59.34	3,928	233,088	45,077	Aug 02 05:00 PM
FILLER LINDA	Director	Aug 01 '24	Sale	279.50	3,928	1,097,876	41,149	Aug 02 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Aug 01 '24	Option Exercise	62.85	16,172	1,016,410	45,579	Aug 02 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Aug 01 '24	Sale	279.84	16,172	4,525,555	29,407	Aug 02 05:00 PM
McGrew Matthew	Officer	Aug 01 '24	Proposed Sale	279.84	16,172	4,525,555		Aug 01 04:28 PM
FILLER LINDA	Director	Aug 01 '24	Proposed Sale	279.50	3,928	1,097,876		Aug 01 12:27 PM
Blair Rainer	Officer	Jul 31 '24	Proposed Sale	280.00	9,007	2,521,960		Jul 31 04:26 PM
Ellis Brian W	Senior Vice President - GC	Jul 25 '24	Sale	275.16	9,600	2,641,536	20,230	Jul 26 05:03 PM
Raskas Daniel	SVP - Corporate Development	Jul 25 '24	Sale	270.51	14,507	3,924,352	23,595	Jul 26 05:03 PM
Zerhouni Elias A.	Director	Jul 15 '24	Option Exercise	52.56	3,289	172,870	37,483	Jul 16 05:01 PM
SCHWIETERS JOHN T	Director	Jul 15 '24	Option Exercise	52.56	3,289	172,870	19,808	Jul 16 05:00 PM
King William	SVP, Strategic Development	May 15 '24	Option Exercise	50.37	12,623	635,821	55,208	May 17 05:10 PM
Blair Rainer	President & CEO	May 16 '24	Sale	265.00	9,005	2,386,325	106,990	May 17 05:08 PM
Blair Rainer	President & CEO	May 14 '24	Option Exercise	59.91	19,085	1,143,435	135,080	May 15 05:00 PM
Blair Rainer	President & CEO	May 14 '24	Sale	255.00	19,085	4,866,675	115,995	May 15 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	May 10 '24	Option Exercise	61.25	25,174	1,541,794	45,338	May 13 05:01 PM
McGrew Matthew	EVP & Chief Financial Officer	May 10 '24	Sale	253.05	46,377	11,735,856	29,407	May 13 05:01 PM
SPOON ALAN G	Director	May 02 '24	Option Exercise	52.56	3,289	172,870	116,910	May 03 05:03 PM
SPOON ALAN G	Director	May 02 '24	Sale	243.58	708	172,455	116,202	May 03 05:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DHR

Danaher Corp

Upgrade your FINVIZ experience